Related Experiment Video
Updated: Aug 26, 2026
Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
Published on: May 10, 2024
[Idiopathic hypereosinophilic syndrome: a case report in an infant]
Insights
Idiopathic hypereosinophilic syndrome is rare in children. Alpha-interferon treatment led to complete remission in a young boy with this condition, demonstrating a favorable outcome.
Area of Science:
- Pediatric Hematology
- Immunology
Background:
- Idiopathic hypereosinophilic syndrome (HES) is a rare disorder characterized by persistent, marked eosinophilia.
- HES in pediatric populations is uncommon and can lead to severe complications if not promptly managed.
Observation:
- A 5-month-old infant presented with significant eosinophilia (187 G/l) and splenomegaly.
- Differential diagnoses including parasitic infections, allergies, and acute leukemia were ruled out.
- Initial treatment with corticosteroids was ineffective.
Findings:
- The patient was diagnosed with idiopathic hypereosinophilic syndrome.
- Treatment with alpha-interferon resulted in complete remission of the eosinophilia.
- This case highlights a successful therapeutic approach for pediatric HES.
Implications:
- Early diagnosis and treatment of pediatric HES are crucial to prevent serious complications such as cardiac dysfunction and hematologic malignancies.
- Alpha-interferon represents a viable treatment option for HES in children.
- Regular hematological and echocardiographic monitoring is essential for patients diagnosed with HES.
Unlabelled:
We report a case of idiopathic hypereosinophilic syndrome in a young child with favorable outcome after treatment with alpha-interferon.
Case Report:
A 5-month-old boy presented with major eosinophilia (187 G/l) associated with splenomegaly. There was no evidence for parasitic or allergic disease. Acute leukemia was suspected but bone marrow smear and medullary caryotype were not compatible. Idiopathic hypereosinophilic syndrome was thus diagnosed. Corticotherapy was started and failed. Finally, complete remission was obtained with alpha-interferon treatment.
Conclusion:
Idiopathic hypereosinophilic syndrome is uncommon in children. Significant complications like cardiac dysfunction or hematologic malignancies can occur. Treatment has to be quickly started, in order to reduce eosinophilia. Haematological and echocardiographic follow-up are required.
